ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

ConV2X Blockchain 2022 Announces NASA TRISH Keynote Speaker

By: WebWire

The 6th Annual ConVerge2Xcelerate (ConV2X) Blockchain in Healthcare 2022 is pleased to announce the distinguished keynote address will be given by Mr. James Hury, Deputy Director and Chief Innovation Officer for the Translational Research Institute for Space Health (TRISH), on September 15, at the Central Public Library, Austin, TX. The institute, powered by NASA, pursues and funds novel research to deliver high-impact scientific and technological solutions to advance space health.

#ConV2X Blockchain 2022 is the acclaimed blockchain health tech event catalyzing C-suite global executives driving a new era of healthcare through policy, partnership and innovation. #ConV2X is the premier destination community presenting real world evidence, strategy, operations, research and trends, where healthcare leadership & breakthrough technology pioneers inspire and guide informed decision making to successfully navigate innovation in healthcare. The event is produced by the leading international Blockchain in Healthcare Today open access peer reviewed journal.

The event creates an irresistible environment for multidisciplinary blockchain, healthcare executives, and future leaders from universities, health systems, payors, consortiums, pharmaceutical & medical device manufacturers, government, NGO, consultants, think tanks, clinicians, VCs/Investors, students and startups.

For details and ticket information please visit https://conv2xsymposium.com/

Contacts:
Tory Cenaj, Founder and Publisher
Partners in Digital Health
t.cenaj@partnersindigitalhealth.com

Rachael Dempsey, MBA
Communications and Education Officer
TRISH
Rachael.Dempsey@bcm.edu

— WebWireID291181 —


Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.